F10 and deep vein thrombosis: In total, 25/27 (92.6%) patients were prescribed enoxaparin for deep vein thrombosis, pulmonary embolism, or both, as compared to only 8/21 (38.1%) patients on warfarin, 2/12 (16.7%) patients on direct thrombin inhibitors, and 29/60 (48.3%) patients on factor Xa inhibitors (Additional file 1: Table 2).